CardioRenal Systems, Inc.: Clinical Trials

5 trials sponsored by CardioRenal Systems, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 active not recruiting, 1 not yet recruiting. 4 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 31Unknown 1

Follow CardioRenal Systems, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury
RenalGuard® Therapy, Standard of Care (SOC) - Cardiac Surgery Associated - Acute Kidney Injury, AKI - Acute Kidney Injury
Not applicableNot yet recruitingCardioRenal Systems, Inc.3002025-09-012025-08-14
Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI
RenalGuard Therapy, Standard of Care (SOC) - AKI - Acute Kidney Injury, Cardiac Surgery Associated - Acute Kidney Injury
Not applicableActive not recruitingCardioRenal Systems, Inc.3002025-02-232026-01-23
Reprieve ADHF EFS IDE
Reprieve Cardiovascular System - Congestive Heart Failure
Not applicableUnknownCardioRenal Systems, Inc.402019-05-012019-03-07
TARGET: A Study to Evaluate the Treatment of Patients With Acute Decompensated Heart Failure (ADHF) Using an Automated Fluid Management System
Reprieve Cardiovascular System - Congestive Heart Failure
Not applicableUnknownCardioRenal Systems, Inc.402017-03-162019-04-01
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
RenalGuard Therapy, Standard Therapy - Contrast Induced Nephropathy
Phase 3UnknownCardioRenal Systems, Inc.3262012-01-012023-02-16

Conditions studied

Acute Kidney Injury (2)  ·  Heart Failure (2)

Interventions

Standard of Care (3)

Countries

Belgium (1)  ·  Germany (1)  ·  Israel (1)  ·  Malaysia (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Charles Davidson, MD (1)  ·  Jacob Raphael, MD (1)  ·  Krishnasamy Professor Dr. Sivakumar (1)  ·  Richard Solomon, MD (1)  ·  Roxana Mehran, MD (1)